Skip to content
Home
News Categories
Social Clips
Hodgkin’s Lymphoma
Non-Hodgkin’s Lymphoma
Clinical Trial
Leukemia & Lymphoma Society
About Lymphoma
Types Of Lymphoma
B-Cell Lymphoma
Benign Lymphoma
Burkitt’s Lymphoma
Cutaneous Lymphoma
Follicular Lymphoma
Indolent Lymphoma
Intestinal Lymphoma
Low Grade Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin’s Lymphoma
Lymphoma Symptoms
Lymphedema
Signs Of Lymphoma
Lymphoma Diagnosis
Lymphoma Prognosis
Treatments
Approved Treatments
CAR T-cell Therapy
Kymriah (Tisagenlecleucel)
Yescarta (KTE-C19)
Adcetris (Brentuximab Vedotin)
Aliqopa (Copanlisib)
Arzerra (Ofatumumab)
Beleodaq (Belinostat)
Bendamustine in Lymphomas
Besponsa (Inotuzumab Ozogamicin)
Calquence (Acalabrutinib)
CPX-351
Gazyva (Obinutuzumab)
Imbruvica (Ibrutinib)
Keytruda for Classical Hodgkin Lymphoma (cHL)
Rituxan (Rituximab)
Rituxan Hycela
Revlimid (lenalidomide)
Velcade (bortezomib)
Venclexta (Venetoclax)
Zydelig (Idelalisib)
Experimental Treatments
ABP798 for Non-Hodgkin’s Lymphoma
ADCT-301 in Lymphomas
AFM11 for B-Cell Lymphoma
AFM13 for Hodgkin’s Lymphoma
ALT-803 for Non-Hodgkin Lymphomas
Betalutin
CMD-003 for Hodgkin’s and non-Hodgkin’s Lymphomas
CX-072
CPI-818
DI-Leu16-IL2
Duvelisib
GWN323
IGN002 for Non-Hodgkin’s Lymphoma
Imfinzi (Durvalumab)
JCAR017 for B-Cell Non-Hodgkin’s Lymphoma (NHL)
JCAR018
KTE-X19
Mogamulizumab
NM-IL-12
Oncoquest-L for Follicular Lymphoma
OXS-1550
PDR001 in Lymphoma
Resimmune
RG7741 (GDC-0575)
Tecentriq (Atezolizumab)
TG-1101 (Ublituximab)
TGR-1202 (Umbralisib)
Xalkori (Crizotinib)
Columns
Overcoming Adversity
Things That Give Me Hope
Life After Lymphoma: A Young Warrior’s Guide to Recovery
Information About COVID-19
Search for:
11218158_10153466984448120_79186711514193322_n
February 20, 2018
by
Radiant Racheli
Print This Page
Leave a Comment
Cancel reply
You must be
logged in
to post a comment.
We use cookies
to enhance your experience on our website.
Privacy Policy
Accept
